ACE and Alzheimer disease: The use of angiotensin receptor blockers highlighted a limited pro-cognitive effect in AD patients (9.4%) [305], while angiotensin-converting enzyme inhibitors (ACE-Is) exhibited less efficacy, possibly due to low BBB penetrance.